{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "exchange": "JPX", "shortName": "MODALIS THERAPEUTICS CORP", "longName": "Modalis Therapeutics Corporation", "messageBoardId": "finmb_547384378", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "market": "jp_market", "esgPopulated": false, "marketState": "PREPRE", "regularMarketChangePercent": -3.041825, "regularMarketPrice": 255.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -98.86, "epsForward": 21.12, "sharesOutstanding": 30092400, "bookValue": 100.094, "fiftyDayAverage": 287.12, "fiftyDayAverageChange": -32.119995, "fiftyDayAverageChangePercent": -0.11186959, "twoHundredDayAverage": 352.85, "twoHundredDayAverageChange": -97.850006, "twoHundredDayAverageChangePercent": -0.27731332, "marketCap": 7790275584, "forwardPE": 12.073863, "priceToBook": 2.5476053, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1596412800000, "priceHint": 2, "regularMarketChange": -8.0, "regularMarketTime": 1683872100, "regularMarketDayHigh": 263.0, "regularMarketDayRange": "252.0 - 263.0", "regularMarketDayLow": 252.0, "regularMarketVolume": 64600, "regularMarketPreviousClose": 263.0, "bid": 255.0, "ask": 256.0, "fullExchangeName": "Tokyo", "financialCurrency": "JPY", "regularMarketOpen": 263.0, "averageDailyVolume3Month": 167275, "averageDailyVolume10Day": 205040, "fiftyTwoWeekLowChange": 16.0, "fiftyTwoWeekLowChangePercent": 0.066945605, "fiftyTwoWeekRange": "239.0 - 602.0", "fiftyTwoWeekHighChange": -347.0, "fiftyTwoWeekHighChangePercent": -0.57641196, "fiftyTwoWeekLow": 239.0, "fiftyTwoWeekHigh": 602.0, "earningsTimestamp": 1683612000, "earningsTimestampStart": 1691042400, "earningsTimestampEnd": 1691388000, "trailingAnnualDividendRate": 0.0, "symbol": "4883.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Y\u2019s Building", "address2": "4th Floor 16-5Nihonbashi-kabuto-cho Chuo-ku", "city": "Tokyo", "zip": "103-0026", "country": "Japan", "website": "https://modalistx.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies fo genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was founded in 2016 and is headquartered in Tokyo, Japan.", "fullTimeEmployees": 36, "companyOfficers": [{"maxAge": 1, "name": "Mr. Haruhiko  Morita", "title": "Co-Founder, Chairman, Pres & CEO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Naoki  Kobayashi M.B.A.", "age": 59, "title": "VP & CFO", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tetsuya  Yamagata M.D., Ph.D.", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}